Heroux Enterprise Value Over E B I T D A from 2010 to 2024

HRX Stock  CAD 31.85  0.09  0.28%   
Heroux Devtek Enterprise Value Over EBITDA yearly trend continues to be very stable with very little volatility. Enterprise Value Over EBITDA is likely to drop to 6.91. During the period from 2010 to 2024, Heroux Devtek Enterprise Value Over EBITDA quarterly data regression pattern had sample variance of  57.65 and median of  9.20. View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
8.6257236
Current Value
6.91
Quarterly Volatility
7.59277571
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Heroux Devtek financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heroux Devtek's main balance sheet or income statement drivers, such as Depreciation And Amortization of 23.3 M, Interest Expense of 15 M or Selling General Administrative of 29.7 M, as well as many indicators such as Price To Sales Ratio of 0.64, Dividend Yield of 0.5 or PTB Ratio of 1.0. Heroux financial statements analysis is a perfect complement when working with Heroux Devtek Valuation or Volatility modules.
  
This module can also supplement various Heroux Devtek Technical models . Check out the analysis of Heroux Devtek Correlation against competitors.

Other Information on Investing in Heroux Stock

Heroux Devtek financial ratios help investors to determine whether Heroux Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Heroux with respect to the benefits of owning Heroux Devtek security.